News
8h
TipRanks on MSNGenmab’s Cervical Cancer Study: A Potential Game-Changer?
Genmab (Otc) (($GMAB)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1b/2 Open-Label ...
All of the winners will be recognized at the ENR New York Best Projects awards event on Nov. 20. For more information about ...
Next-generation claudin 18.2 ISAC BDC-4182 now in Phase 1 dose-escalation study Cash balance of $48.5 million as of June 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results